To our knowledge, this is the first report to investigate the clinical utility of comprehensive measurement of autoimmune disease-related Abs, such as ANA, Tg Ab, TPO Ab, GAD Ab, AchR Ab, and PA-IgG, in cancer patients treated with ICIs. The gene discussed is BTG3; the disease is cancer.